HER2 and CD24

Preclinical Study Highlights HER2 and CD24 as Radiotheranostic Targets in Endometrial Cancer

Mouse immunoPET with 89Zr-labeled antibodies showed especially strong CD24 tumor uptake, prompting calls for clinical translation.